title: Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
abstract: Human immunodeficiency virus type-1 (HIV-1) cytotoxic T lymphocyte (CTL) epitopes have largely been defined in Caucasian populations infected with clade B virus. Identification of potentially protective CTL epitopes in non-B clade-infected African subjects is important for vaccine development. In a study of CTL responses in clade A-infected Gambians, using cytotoxicity, interferon-gamma (IFN-gamma) enzyme-linked immunospot (ELISpot) and HLA-B53-peptide tetramer assays, we identified three HLA-B53-restricted epitopes in HIV-1 gag p24. CTL specific for an epitope in a highly immunogenic region of the p24 protein showed no cross-reactivity to other HIV-1 clades. Two of the epitopes would not have been predicted from the peptide-binding motif due to the absence of a proline anchor at position 2. Structural analysis of HLA-B53 and its relative, HLA B35, enabled us to re-define the peptide-binding motif to include other P2 anchors. These results demonstrate the value of combined immunological and structural analyses in defining novel CTL epitopes and have implications for HIV-1 vaccine design.
authors.affiliation: MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB.
authors.forename: L
authors.initials: L
authors.lastname: Dorrell
authors.forename: B E
authors.initials: BE
authors.lastname: Willcox
authors.forename: E Y
authors.initials: EY
authors.lastname: Jones
authors.forename: G
authors.initials: G
authors.lastname: Gillespie
authors.forename: H
authors.initials: H
authors.lastname: Njai
authors.forename: S
authors.initials: S
authors.lastname: Sabally
authors.forename: A
authors.initials: A
authors.lastname: Jaye
authors.forename: K
authors.initials: K
authors.lastname: DeGleria
authors.forename: T
authors.initials: T
authors.lastname: Rostron
authors.forename: E
authors.initials: E
authors.lastname: Lepin
authors.forename: A
authors.initials: A
authors.lastname: McMichael
authors.forename: H
authors.initials: H
authors.lastname: Whittle
authors.forename: S
authors.initials: S
authors.lastname: Rowland-Jones
mesh_terms: D000595:Amino Acid Sequence; D002461:Cell Line, Transformed; D003429:Cross Reactions; D018984:Epitopes, T-Lymphocyte / Q000737:chemistry / Q000276:immunology; D015683:Gene Products, gag / Q000737:chemistry / Q000276:immunology*; D015488:HIV Antigens / Q000737:chemistry / Q000276:immunology*; D016655:HIV Core Protein p24 / Q000737:chemistry / Q000276:immunology*; D015658:HIV Infections / Q000097:blood / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D015498:HIV-2 / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014764:Viral Proteins; D054301:gag Gene Products, Human Immunodeficiency Virus
chemical_list: D018984:Epitopes, T-Lymphocyte; D015683:Gene Products, gag; D015488:HIV Antigens; D016655:HIV Core Protein p24; D006680:HLA Antigens; C078438:HLA-B53 antigen; D010455:Peptides; D014764:Viral Proteins; D054301:gag Gene Products, Human Immunodeficiency Virus; C054858:p17 protein, Human Immunodeficiency Virus Type 1